Login to Your Account



Other News To Note


Friday, November 2, 2012

• Cardiome Pharma Corp., of Vancouver, British Columbia, said Nasdaq granted the firm's request for an additional 180 days to regain compliance with the $1 minimum bid price requirement.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription